The Effectiveness of 4D Image Acquisition and Post-processing With Vios Works

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

ACTIVE_NOT_RECRUITING

Clinical Phase

NA

Total Enrollment

250 participants

Study Classification

INTERVENTIONAL

Study Start Date

2018-02-20

Study Completion Date

2023-06-20

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study aims to evaluate the effectiveness of 4D image acquisition and post-processing with Vios Works for the evaluation of 3D images acquired on GE Magnetic Resonance Imaging scanners. Specifically, the investigators propose to evaluate the following:

1. Image acquisition time using traditional 2D and new 4D processing techniques;
2. Image quality for 2D and 4D processing techniques subjectively
3. Post-processing time for the two techniques.
4. Correlation of overall Left ventricular and right ventricular volumes and functions and aortic and pulmonic flow studies using the two techniques.
5. The study will monitor any changes in patient diagnoses or treatment resulting from any differences in interpretations between the two processes.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

A Post-Marketing Study for On Label Evaluation of the GE Vscan Ultrasound Imaging System

NCT01076296

Left Ventricular Dysfunction Right Ventricular Dysfunction Pulmonary Hypertension +1 more

COMPLETED

Optimizing Radiation Dose and Utilizing Wearable Devices to Reduce Arrhythmia Risk in Patients Undergoing Thoracic Radiotherapy: A Prospective Cohort Study

NCT06897189

Cardiotoxicity Thoracic Radiotherapy Wearable Electronic Devices +2 more

NOT_YET_RECRUITING

A Study of Mayo Clinic CV Research Heart & Voice Study

NCT07224685

Cardiovascular Diseases

RECRUITING

Testing VIRTUES Patient Care Sets in Cardiac Patients (VIRTUES Cardiac Care)

NCT05452356

Heart Diseases Arrhythmias, Cardiac Atrial Fibrillation +2 more

RECRUITING

Combining Accelerometer, Gyroscope, Sound, Electrocardiography and Photoplethysmography Data in Cardiac Monitoring

NCT06422468

Atrial Fibrillation

RECRUITING NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Traditional scanning and post-processing of 2D Cardiac Magnetic Resonance images (CMRI) is highly technical and time consuming, with many exams requiring one to two hours to complete. In addition, performance of 2D scans often requires expert technologists working closely with the clinician imaging expert. These factors limit the general clinical utility of current generation cardiac MRI.

In order to address these factors, many researchers began to explore the use of 4D image acquisition and post processing to shorten exam time. These researchers have documented success at these efforts but, to the best of the current investigators' knowledge, such advanced imaging acquisition and post-processing systems are not readily commercially available in the US.

Recently GE teamed with Vios-Works for MRI to provide a cloud-based visualization platform for 4D MRI that provides quantitative and structured reporting in the post processing environment that makes use of advance MR imaging acquisition techniques. The images can be accessed by the interpreter and reviewed and manipulated in order to assess cardiac function and flow retrospectively, which, prior to this innovation, only has been available for computed tomography (CT) generated images.

This investigative team hypothesizes that the use of 4D imaging will result in reduced time for acquisition (approximately 6 minutes as opposed to 1 hour), and improvement of diagnostic capability.

Images will be acquired using the current standard 2D acquisition protocol for routine clinical cardiac MRI. A repeat acquisition will be completed using the new protocol for 4D imaging acquisition. This will require that patient exams be extended in length by six minutes for those enrolled in the study. The investigators will evaluate the image quality of the two techniques and grade them according to a scale of 1 to 3 with 1 being excellent cardiac borders easily identified; 2 - acceptable: cardiac borders acceptably identified; and 3, non-diagnostic. The investigators will specifically focus on the evaluation of cardiac function of both right and left ventricular function as well as flow analysis of both the aortic and pulmonic valves.

For each method, technician time and MD time will be collected. The exam will go through post processing for standard 2D, following by the new 4D post processing technique. Time for post processing will be collected. All subjects who agree will receive both a 2D and a 4D MRI. The investigators will evaluate inter and intra reader reliability by having all readers read the first 15 exams, and then read them a second time after two weeks in a different order Readers showing variation in performance will be retrained on interpretation of 4D MRI before reading scans for the study.

Once readers have been trained, the study will require that all 2D and 4D exams be read by two readers. The exams will be assigned randomly to readers using the Biostatistician Office random assignment services.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Cardiac Disease

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Each participant will receive tradition 2D Cardiac imaging as ordered per standard of care. Then, the participant will receive a 4D image, requiring 6 to 10 additional minutes in the MRI scanner. The 2D and 4D images will be interpreted by readers blinded to the results of the alternate modality. Inter- and intra-reader reliability will be assessed.

Primary Study Purpose

DIAGNOSTIC

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

All Enrollees

Intervention: Diagnostic test

All enrollees will receive a 4D MRI as a research intervention using imaging software for 4 dimensional images for Cardiac MRI

Group Type EXPERIMENTAL

Imaging software for 4 dimensional images for Cardiac MRI

Intervention Type DEVICE

All enrollees will receive Cardiac MRI scans using Imaging software for 4 dimensional images for Cardiac MRI

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Imaging software for 4 dimensional images for Cardiac MRI

All enrollees will receive Cardiac MRI scans using Imaging software for 4 dimensional images for Cardiac MRI

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* 18 years of age or older
* with a valid prescription for Cardiac MRI for the following: Congenital heart disease/Shunts, Valvular heart disease, Pulmonary Hypertension, Aortic Disease, Hypertrophic Cardiomyopathy (HCM)
* receiving Standard of Care services at the MRI Center
* consent to participate in the 4D trial

Exclusion Criteria

Patients with any of the following will be excluded:

* Pacemaker or ICD implanted
* ICDs implanted
* Temporary Pacemakers (e.g. transvenous temporary wires)
* Leads that are abandoned (capped or retained leads not attached to device)
* Non-transvenous leads (e.g. epicardial leads)
* Leads that have no fixation (e.g. floating leads)
* A lead that is known to be fractured
* Any other metallic objects that, in the opinion of the safety officer would compromise patient safety

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No